Procurement of medicines and infusion solutions subject to approval by the Ministry of Health and the Health Insurance Fund

Deadline:20 Jul 2026, 08:00

Tender information
Скопски
Type
Contract
Procedure
Open procedure
Duration
12 months
Procurement of medicines and infusion solutions subject to approval by the Ministry of Health and the Health Insurance Fund

PART 1 famotidine

PART 1 famotidine

PART 2 bisacodyl

PART 2 bisacodyl

PART 3 tranexamic acid

PART 3 tranexamic acid

PART 4 coagulation factor IX, II, VII and X in combination

PART 4 coagulation factor IX, II, VII and X in combination

PART 5 magnesium sulfate

PART 5 magnesium sulfate

PART 6 phenylephrine

PART 6 phenylephrine

PART 7 ephedrine

PART 7 ephedrine

PART 8 esmolol

PART 8 esmolol

PART 9 hyoscine butylbromide

PART 9 hyoscine butylbromide

PART 10 moxifloxacin

PART 10 moxifloxacin

PART 11 linezolid

PART 11 linezolid

PART 12 caspofungin

PART 12 caspofungin

PART 13 lidocaine

PART 13 lidocaine

PART 14 amantadine

PART 14 amantadine

PART 15 amantadine

PART 15 amantadine

PART 16 promazine

PART 16 promazine

PART 17 povidone-iodine

PART 17 povidone-iodine

PART 18 desflurane

PART 18 desflurane

PART 19 rivaroxaban

PART 19 rivaroxaban

PART 20 vasopressin (argipressin)

PART 20 vasopressin (argipressin)

PART 21 dexmedetomidine

PART 21 dexmedetomidine

PART 22 dantrolene

PART 22 dantrolene

PART 23 ibuprofen

PART 23 ibuprofen

PART 24 ibuprofen

PART 24 ibuprofen

PART 25 human fibrinogen

PART 25 human fibrinogen

PART 26 ropivacaine

PART 26 ropivacaine

PART 27 ceftarolin fosamil

PART 27 ceftarolin fosamil

PART 28 lactobacillus, bifidobacterium

PART 28 lactobacillus, bifidobacterium

PART 29 fosfomycin

PART 29 fosfomycin

PART 30 isavuconazole

PART 30 isavuconazole

PART 31 sugammadex

PART 31 sugammadex

PART 32 human plasma proteins

PART 32 human plasma proteins

PART 33 tygecycline

PART 33 tygecycline

PART 34 fondaparinux

PART 34 fondaparinux

PART 35 ceftazidime,avibactam

PART 35 ceftazidime,avibactam

PART 36 chlorpromazine

PART 36 chlorpromazine

PART 37 ipratropium bromide

PART 37 ipratropium bromide

PART 38 adenosine

PART 38 adenosine

PART 39 lidocaine

PART 39 lidocaine

PART 40 paracetamol, ibuprofen

PART 40 paracetamol, ibuprofen

PART 41 landiolol hydrochloride

PART 41 landiolol hydrochloride

PART 42 ceftolozane, tazobactam

PART 42 ceftolozane, tazobactam

Buyer
PHI Univ. Cl. for traumatology, orthopedic diseases, anesthesia, resuscitation and intensive treatment and emergency center
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Open for offers
24 days left
Important dates
25 Jun - Publication date
20 Jul - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.